TR200301931T2 - Saç gelişiminde 3 konumundaki siklosporin türevlerinin kullanılması - Google Patents

Saç gelişiminde 3 konumundaki siklosporin türevlerinin kullanılması

Info

Publication number
TR200301931T2
TR200301931T2 TR2003/01931T TR200301931T TR200301931T2 TR 200301931 T2 TR200301931 T2 TR 200301931T2 TR 2003/01931 T TR2003/01931 T TR 2003/01931T TR 200301931 T TR200301931 T TR 200301931T TR 200301931 T2 TR200301931 T2 TR 200301931T2
Authority
TR
Turkey
Prior art keywords
hair growth
cyclosporine derivatives
active ingredient
cyclosporin
promoting agent
Prior art date
Application number
TR2003/01931T
Other languages
English (en)
Inventor
Kim Sang-Nyun
Ahn Ho-Jeong
Lee Chang-Woo
Lee Min-Ho
Kim Jung-Hun
Kim Jong-Il
Kim Seung-Jin
Cho Ho-Song
Lee Heon-Sik
Kim Hyung-Jin
Original Assignee
Lg Household & Health Care Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Household & Health Care Ltd. filed Critical Lg Household & Health Care Ltd.
Publication of TR200301931T2 publication Critical patent/TR200301931T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Mevcut bulus, aktif bir bilesen olarak bir siklosporin türevi ihtiva eden saç gelisimini tesvik edici bir maddeyi ve daha özel olarak da aktif bir bilesen olarak 3 konumunda ikame edilmis bir siklosporin A türevi ihtiva eden saç gelisimini tesvik edici bir maddeyi sunar.
TR2003/01931T 2001-05-11 2002-05-11 Saç gelişiminde 3 konumundaki siklosporin türevlerinin kullanılması TR200301931T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2001-0025682A KR100465012B1 (ko) 2001-05-11 2001-05-11 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제

Publications (1)

Publication Number Publication Date
TR200301931T2 true TR200301931T2 (tr) 2004-09-21

Family

ID=19709334

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/01931T TR200301931T2 (tr) 2001-05-11 2002-05-11 Saç gelişiminde 3 konumundaki siklosporin türevlerinin kullanılması

Country Status (17)

Country Link
US (2) US6790830B2 (tr)
EP (1) EP1387660B1 (tr)
JP (1) JP4214181B2 (tr)
KR (1) KR100465012B1 (tr)
CN (1) CN1248671C (tr)
AT (1) ATE473730T1 (tr)
AU (1) AU2002258271B2 (tr)
BR (1) BRPI0209619B8 (tr)
CA (1) CA2446971C (tr)
DE (1) DE60237003D1 (tr)
ES (1) ES2348225T3 (tr)
MX (1) MXPA03010027A (tr)
PL (1) PL208536B1 (tr)
RU (1) RU2291682C2 (tr)
TR (1) TR200301931T2 (tr)
WO (1) WO2002092032A1 (tr)
ZA (1) ZA200308532B (tr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020039528A (ko) * 2000-11-22 2002-05-27 조명재 사이클로스포린 7- 티오아미드 유도체를 유효성분으로하는 모발성장촉진제
KR100865211B1 (ko) * 2001-10-26 2008-10-23 주식회사 엘지생활건강 비면역 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 유효성분으로 하는 항암 화학요법 기인 탈모증상 억제제
US6987090B2 (en) * 2002-05-09 2006-01-17 Lg Household & Health Care Ltd. Use of 3-position cyclosporin derivatives for hair growth
JP2006524232A (ja) 2003-03-17 2006-10-26 アルバニー モレキュラー リサーチ インコーポレーティッド 新規サイクロスポリン
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
JP2008514701A (ja) 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
WO2006041631A2 (en) 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US20090041442A1 (en) * 2006-03-06 2009-02-12 Rouse Jr Martin D Thermal Vaporizer Apparatus
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
US20100305047A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
US8470376B2 (en) 2009-06-15 2013-06-25 Kao Corporation NFAT signal inhibitor and calcineurin inhibitor
PL2651965T3 (pl) 2010-12-15 2019-04-30 Contravir Pharmaceuticals Inc Cząsteczki analogów cyklosporyny modyfikowane w aminokwasach 1 i 3
RU2479872C1 (ru) * 2012-01-11 2013-04-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ коррекции ишемических нарушений, возникших в результате реперфузионной травмы печени
EP2705856A1 (en) 2012-09-07 2014-03-12 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. Compounds for the treatment of neurodegenerative disorders
KR102469342B1 (ko) * 2021-06-14 2022-11-21 주식회사 오리엔트바이오 환형 펩타이드를 포함하는 방출조절형 국소주사용 조성물 및 이의 제조방법
FR3162624A1 (fr) * 2024-05-31 2025-12-05 L'oreal Composition comprenant au moins un actif antipelliculaire, au moins un agent antioxydant et au moins 35% en poids d’un monoalcool en C1 à C6

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243008A (ja) 1984-05-17 1985-12-03 Wakamoto Pharmaceut Co Ltd 発毛養毛剤
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
JPS6219512A (ja) 1985-07-17 1987-01-28 Shiseido Co Ltd 養毛剤
JPS6219513A (ja) 1985-07-17 1987-01-28 Shiseido Co Ltd 養毛剤
CH679119A5 (tr) 1988-05-13 1991-12-31 Sandoz Ag
US5284826A (en) * 1989-07-24 1994-02-08 Sandoz Ltd. 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
GB9203886D0 (en) * 1992-02-24 1992-04-08 Sandoz Ltd Improvements in or relating to organic compounds
SE517678C2 (sv) * 1994-07-12 2002-07-02 Lipocore Holding Ab Lipofila bärarpreparat med en kontinuerlig lipidfas
JPH07316023A (ja) * 1994-05-26 1995-12-05 Shiseido Co Ltd 育毛料
ATE209216T1 (de) * 1995-07-17 2001-12-15 Chem Ag C Cyclosporin-derivate mit anti-hiv-wirkung
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
CA2334730C (en) * 1998-06-12 2009-09-29 C-Chem Ag Novel cyclosporins
FR2780061B1 (fr) * 1998-06-22 2001-09-07 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine
AU3861900A (en) 1999-03-05 2000-09-21 University Of Texas Southwestern Medical Center, The Method of treating hair loss using non-immunosuppressive compounds
AU1420801A (en) * 1999-11-19 2001-05-30 Lg Household & Health Care Ltd. Use of nonimmunosuppressive cyclosporin derivatives for hair growth
US6521595B1 (en) * 1999-11-19 2003-02-18 Lg Chemical, Ltd. Nonimmunosuppressive [γ-hydroxy-methylleucine4] cyclosporin A, hair growth stimulator and external composition for skin using the same
KR100316604B1 (ko) * 1999-11-19 2001-12-12 성재갑 모발 성장 효과를 갖는 비면역억제 사이클로스포린 에이유도체
KR20020039528A (ko) * 2000-11-22 2002-05-27 조명재 사이클로스포린 7- 티오아미드 유도체를 유효성분으로하는 모발성장촉진제
KR100360716B1 (ko) * 2000-11-22 2002-11-13 주식회사 엘지생활건강 사이클로스포린 에이 7- 티오아미드 유도체를유효성분으로 하는 모발성장촉진제
KR100681670B1 (ko) * 2001-02-14 2007-02-09 주식회사 엘지생활건강 [감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제
KR100695610B1 (ko) * 2001-05-15 2007-03-14 주식회사 엘지생활건강 비면역성 발모성분인 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 함유한 두피 및 경피용 제제 조성물
KR100695611B1 (ko) * 2001-05-17 2007-03-14 주식회사 엘지생활건강 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린유도체를 유효성분으로 하는 모발 성장 촉진제

Also Published As

Publication number Publication date
ATE473730T1 (de) 2010-07-15
BRPI0209619B8 (pt) 2021-05-25
MXPA03010027A (es) 2005-09-08
EP1387660A1 (en) 2004-02-11
BRPI0209619B1 (pt) 2015-05-19
ZA200308532B (en) 2004-07-01
JP4214181B2 (ja) 2009-01-28
US20030186857A1 (en) 2003-10-02
CA2446971A1 (en) 2002-11-21
BR0209619A (pt) 2004-03-30
DE60237003D1 (de) 2010-08-26
PL366407A1 (en) 2005-01-24
EP1387660B1 (en) 2010-07-14
KR20020086041A (ko) 2002-11-18
EP1387660A4 (en) 2006-05-17
JP2004530685A (ja) 2004-10-07
CN1507339A (zh) 2004-06-23
CN1248671C (zh) 2006-04-05
ES2348225T3 (es) 2010-12-01
US20030207798A1 (en) 2003-11-06
RU2003135846A (ru) 2005-03-27
US6790830B2 (en) 2004-09-14
KR100465012B1 (ko) 2005-01-13
US6762164B2 (en) 2004-07-13
AU2002258271B2 (en) 2006-06-29
PL208536B1 (pl) 2011-05-31
WO2002092032A1 (en) 2002-11-21
CA2446971C (en) 2011-07-05
RU2291682C2 (ru) 2007-01-20

Similar Documents

Publication Publication Date Title
TR200301931T2 (tr) Saç gelişiminde 3 konumundaki siklosporin türevlerinin kullanılması
ZA200000603B (en) Use of stilbene derivatives substituted in position 3, as deodrorant active agents in cosmetic compositions.
PT1089704E (pt) Locao tricologica para aplicacao topica
MA26317A1 (fr) Preparations combinees de derives de 1,1-dioxyde de 1,4-benzothiepine avec d'autres principes actifs et leur utilisation.
EP1340501A4 (en) EMBELLISHING FOODS AND BEVERAGES AND EMBELLISHING PERORAL PREPARATIONS
ATE253351T1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
AU2002302544A1 (en) Active ingredient combinations for hair-dyeing agents
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
DE60116359D1 (de) Kahalalid f formulierung
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
AU2003274785A1 (en) Use of 3-position cyclosporin derivatives for hair growth
AU2001269252A1 (en) Alcohol-free base for aqueous perfume composition, and alcohol-free aqueous perfume composition comprising same
DE60131085D1 (de) Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika
MXPA03001826A (es) Derivados de arilpiperazina.
SE0001916D0 (sv) Novel formulation
EP0929217A4 (en) SORDARINE DERIVATIVES
DK1189615T3 (da) Endoparasiticid synergistisk kombination indeholdende cykliske depsipeptider og piperaziner
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
EP1007032A4 (en) 4-Cyano-4-DEFORMYLSORDARIZIN DERIVATIVES
AR026890A1 (es) Composiciones de tenocitos, preparaciones y utilizaciones
HUP0402072A3 (en) Glycine derivatives containing 1,3-oxazole or -thiazole ring and drugs containing the same as active ingredient
EP1007031A4 (en) 4-CYANO-4-DEFORMYLSORDARINE DERIVATIVES
ATE251619T1 (de) 1,4-dioxacycloalkan-2-one und 1,4-dioxacycloalken-2-one
DE59901831D1 (de) Wirkstoffkombinationen und Desinfektionsmittel, Konservierungsmittel und Antiseptika dieselben enthaltend
PT1194158E (pt) Uso da proteina uk 114 para inibir a rejeicao do transplante de orgaos